Home · Articles · Tirzepatide prices, November 2026
Market report · November 2026Compounded tirzepatide prices in November 2026: 48 sellers, what changed, and who is cheapest
As of November 5, 2026, 48 of 67 sellers we checked publish a compounded tirzepatide price. The lowest all-in month-to-month price is Collective at about $86 per 30 days (includes a required membership); with no membership it is SnagRx at $119; over twelve months it is Collective at $1,027. The median is $219. NexLife, our top-rated provider, charges from $115 a month on a 12-month plan and $129 month to month.
Compounded tirzepatide prices in November 2026, in one table
We checked 67 online sellers of compounded tirzepatide on November 4, 2026 and re-read NexLife after its price cut on November 5. 48 publish a price on their own website; the rest show a price only after an intake quiz, sell only brand drugs, or could not be read. Printed prices run from $71 to $399 per 30 days. The median month-to-month all-in price is $219.
| Category | Seller | Price | Condition |
|---|---|---|---|
| Lowest all-in, month to month | Collective | about $86 per 30 days | includes a required membership |
| Lowest with no membership | SnagRx | $119 per 30 days | sale price |
| Lowest on a longer plan | PreventiveMD | $97 per 30 days | paid up front |
| Cheapest 12 months | Collective | $1,027 | month to month |
| Lowest advertised figure | Wellmedr (welludr) | $71 per 30 days | ships every 4 weeks; its FAQ says a "per month" figure can be a prepaid plan total divided |
| Our top-rated provider | NexLife | $115 on 12 months; $129 month to month | same at every dose, no membership |
What changed since October?
For the sellers we read on both October 14 and November 4–5, most prices did not move. The changes were NexLife’s cut on November 5 and a lower headline at Wellmedr, whose page does not say which plan length the price belongs to.
| Seller | October 14, 2026 | November 4–5, 2026 | Change |
|---|---|---|---|
| NexLife | $169 month to month; $139 on 12 months | $129 month to month; $115 on 12 months | Lower |
| Wellmedr (welludr) | $89 a month ("Fall sale") | $71 a month (plan length not shown) | Lower headline |
| Mondae | $126 month to month; $114 on 6 months | Same; headline now shows "from $114" | No change |
| Eden | $129, no membership | $129, no membership | No change |
| SnagRx | $119 sale ($149 in its terms) | $119 sale, "lock in for life" | No change |
| Collective | $69 + $199 yearly membership | $69 + $199 yearly membership | No change |
| Ivim Health | from $117 + $74.99 monthly fee | from $117 + $74.99 monthly fee | No change |
Which seller is cheapest over a full year?
Over twelve months, Collective is lowest at $1,027 (month to month). NexLife’s 12-month plan totals $1,380, the 3rd lowest of 33 sellers that print a full-year price.
Each seller’s cheapest printed way to buy a year, including required membership fees. Prepaid plans are usually final once shipped.
Chart data
| Item | Value | Basis |
|---|---|---|
| Collective | $1,027 | month to month |
| Maximus | $1,200 | 12-month plan, paid up front |
| NexLife | $1,380 | 12-month plan |
| Mondae | $1,387 | 6-month plan, paid up front |
| SnagRx | $1,428 | month to month |
| Yucca Health | $1,428 | 12-month plan, paid up front |
| Ozari Health | $1,521 | 3-month plan, paid up front |
| CoraDoc | $1,524 | 12-month plan, paid up front |
| Eden | $1,548 | month to month |
| Affinity Direct | $1,566 | 3-month plan, paid up front |
Why “from” prices are hard to compare
Only 28 of 47 offers are a price you can simply pay for one month. The rest are plan rates, first-month offers, prices that need a membership, 4-week billing or figures the seller’s own pages contradict. That is why our tables turn every price into a 30-day cost and keep month-to-month and plan prices apart.
An offer can fall in more than one of the last four groups.
Chart data
| Item | Value | Basis |
|---|---|---|
| Month to month | 28 | a price you can pay for one month |
| Longer or prepaid plan only | 8 | headline is a plan rate |
| Plan length not stated | 5 | “from” with no term |
| Conflicting figures | 6 | seller pages disagree |
| First-month offer | 5 | price rises after month one |
| Separate membership fee | 5 | paid on top of medication |
| Billed every 4 weeks | 8 | 13 bills a year |
| Price rises with dose | 5 | top dose costs more |
- 5 first-month offers rise after month one.
- 5 sellers add a membership or program fee.
- 8 offers bill every 4 weeks, 13 times a year.
- 22 offers list one price at every dose; 5 rise with dose.
What should you check besides price?
Compounded tirzepatide is not FDA-approved. FDA has received adverse-event reports for compounded GLP-1s, some linked to dosing errors, so check that the seller names the pharmacy that fills the prescription, that a licensed clinician reviews your history, and that the refund terms are written down before you pay. See every offer, with its conditions and source page, in our full price table or download the data.
Frequently asked questions
What is the cheapest compounded tirzepatide in November 2026?
Month to month, Collective is lowest all-in at about $86 per 30 days (includes a required membership). With no membership, SnagRx is lowest at $119. Over twelve months, Collective is lowest at $1,027.
What is the average price of compounded tirzepatide?
The median month-to-month all-in price across 29 sellers that print one was $219 per 30 days on November 4–5, 2026.
Did compounded tirzepatide prices go down in November 2026?
For most sellers we read in both October and November, prices were unchanged. NexLife cut its prices on November 5, 2026, to $129 month to month and $115 on a 12-month plan.
Why do “from” prices differ so much from what I pay?
A “from” price is usually a first-month offer, the per-month rate of a prepaid plan, the lowest dose, or a price before a required membership. Converting each price to a 30-day all-in cost makes them comparable.
How many sellers publish a compounded tirzepatide price?
48 of the 67 sellers we checked on November 4, 2026 showed a price on their own website.
Sources
Informational only, not medical advice. Compounded drugs are not FDA-approved and are not the same products as Mounjaro® or Zepbound® (trademarks of Eli Lilly and Company). Prices and policies were read on the companies' own pages on the date shown and can change.